Anne Samuel
Stock Analyst at JP Morgan
(3.88)
# 710
Out of 4,479 analysts
31
Total ratings
57.69%
Success rate
8.35%
Average return
Main Sectors:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PINC Premier | Maintains: Neutral | $23 → $21 | $18.58 | +13.02% | 3 | May 28, 2024 | |
| DOCS Doximity | Upgrades: Neutral | $25 | $27.47 | -8.99% | 3 | Apr 25, 2024 | |
| HQY HealthEquity | Maintains: Overweight | $86 → $108 | $86.62 | +24.68% | 4 | Apr 2, 2024 | |
| EVH Evolent Health | Maintains: Overweight | $53 → $52 | $18.41 | +182.46% | 3 | Mar 15, 2024 | |
| VEEV Veeva Systems | Maintains: Neutral | $183 → $222 | $181.67 | +22.20% | 3 | Mar 13, 2024 | |
| RCM R1 RCM | Downgrades: Neutral | $20 → $11 | $12.56 | -12.42% | 3 | Dec 13, 2023 | |
| HCAT Health Catalyst | Upgrades: Overweight | $14 → $11 | $6.07 | +81.22% | 2 | Dec 13, 2023 | |
| IQV IQVIA Holdings | Maintains: Overweight | $262 → $239 | $208.49 | +14.63% | 2 | Nov 13, 2023 | |
| PGNY Progyny | Maintains: Overweight | $58 → $57 | $28.38 | +100.85% | 3 | Oct 9, 2023 | |
| CCSI Consensus Cloud Solutions | Maintains: Neutral | $51 → $41 | $16.55 | +147.73% | 2 | May 15, 2023 | |
| OMCL Omnicell | Maintains: Neutral | $140 → $57 | $26.65 | +113.88% | 2 | Nov 18, 2022 | |
| MDRX Veradigm | Maintains: Underweight | $19 → $20 | $9.50 | +110.53% | 1 | Nov 18, 2022 |
Premier
May 28, 2024
Maintains: Neutral
Price Target: $23 → $21
Current: $18.58
Upside: +13.02%
Doximity
Apr 25, 2024
Upgrades: Neutral
Price Target: $25
Current: $27.47
Upside: -8.99%
HealthEquity
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $86.62
Upside: +24.68%
Evolent Health
Mar 15, 2024
Maintains: Overweight
Price Target: $53 → $52
Current: $18.41
Upside: +182.46%
Veeva Systems
Mar 13, 2024
Maintains: Neutral
Price Target: $183 → $222
Current: $181.67
Upside: +22.20%
R1 RCM
Dec 13, 2023
Downgrades: Neutral
Price Target: $20 → $11
Current: $12.56
Upside: -12.42%
Health Catalyst
Dec 13, 2023
Upgrades: Overweight
Price Target: $14 → $11
Current: $6.07
Upside: +81.22%
IQVIA Holdings
Nov 13, 2023
Maintains: Overweight
Price Target: $262 → $239
Current: $208.49
Upside: +14.63%
Progyny
Oct 9, 2023
Maintains: Overweight
Price Target: $58 → $57
Current: $28.38
Upside: +100.85%
Consensus Cloud Solutions
May 15, 2023
Maintains: Neutral
Price Target: $51 → $41
Current: $16.55
Upside: +147.73%
Omnicell
Nov 18, 2022
Maintains: Neutral
Price Target: $140 → $57
Current: $26.65
Upside: +113.88%
Veradigm
Nov 18, 2022
Maintains: Underweight
Price Target: $19 → $20
Current: $9.50
Upside: +110.53%